276 related articles for article (PubMed ID: 19682101)
1. Abacavir and risk of myocardial infarction in HIV-infected patients on highly active antiretroviral therapy: a population-based nationwide cohort study.
Obel N; Farkas DK; Kronborg G; Larsen CS; Pedersen G; Riis A; Pedersen C; Gerstoft J; Sørensen HT
HIV Med; 2010 Feb; 11(2):130-6. PubMed ID: 19682101
[TBL] [Abstract][Full Text] [Related]
2. Impact of individual antiretroviral drugs on the risk of myocardial infarction in human immunodeficiency virus-infected patients: a case-control study nested within the French Hospital Database on HIV ANRS cohort CO4.
Lang S; Mary-Krause M; Cotte L; Gilquin J; Partisani M; Simon A; Boccara F; Costagliola D;
Arch Intern Med; 2010 Jul; 170(14):1228-38. PubMed ID: 20660842
[TBL] [Abstract][Full Text] [Related]
3. Abacavir use and risk of acute myocardial infarction and cerebrovascular events in the highly active antiretroviral therapy era.
Bedimo RJ; Westfall AO; Drechsler H; Vidiella G; Tebas P
Clin Infect Dis; 2011 Jul; 53(1):84-91. PubMed ID: 21653308
[TBL] [Abstract][Full Text] [Related]
4. Risk of cerebrovascular events in persons with and without HIV: a Danish nationwide population-based cohort study.
Rasmussen LD; Engsig FN; Christensen H; Gerstoft J; Kronborg G; Pedersen C; Obel N
AIDS; 2011 Aug; 25(13):1637-46. PubMed ID: 21646903
[TBL] [Abstract][Full Text] [Related]
5. Risk of cataract surgery in HIV-infected individuals: a Danish Nationwide Population-based cohort study.
Rasmussen LD; Kessel L; Molander LD; Pedersen C; Gerstoft J; Kronborg G; Obel N
Clin Infect Dis; 2011 Dec; 53(11):1156-63. PubMed ID: 21998282
[TBL] [Abstract][Full Text] [Related]
6. No risk of myocardial infarction associated with initial antiretroviral treatment containing abacavir: short and long-term results from ACTG A5001/ALLRT.
Ribaudo HJ; Benson CA; Zheng Y; Koletar SL; Collier AC; Lok JJ; Smurzynski M; Bosch RJ; Bastow B; Schouten JT;
Clin Infect Dis; 2011 Apr; 52(7):929-40. PubMed ID: 21427402
[TBL] [Abstract][Full Text] [Related]
7. Risk of myocardial infarction in patients with HIV infection exposed to specific individual antiretroviral drugs from the 3 major drug classes: the data collection on adverse events of anti-HIV drugs (D:A:D) study.
Worm SW; Sabin C; Weber R; Reiss P; El-Sadr W; Dabis F; De Wit S; Law M; Monforte AD; Friis-Møller N; Kirk O; Fontas E; Weller I; Phillips A; Lundgren J
J Infect Dis; 2010 Feb; 201(3):318-30. PubMed ID: 20039804
[TBL] [Abstract][Full Text] [Related]
8. Incidence of abacavir hypersensitivity reactions in euroSIDA.
Bannister WP; Friis-Møller N; Mocroft A; Viard JP; van Lunzen J; Kirk O; Gargalianos P; Bánhegyi D; Chiesi A; Lundgren JD;
Antivir Ther; 2008; 13(5):687-96. PubMed ID: 18771052
[TBL] [Abstract][Full Text] [Related]
9. Hospitalization for pneumonia among individuals with and without HIV infection, 1995-2007: a Danish population-based, nationwide cohort study.
Sogaard OS; Lohse N; Gerstoft J; Kronborg G; Ostergaard L; Pedersen C; Pedersen G; Sørensen HT; Obel N
Clin Infect Dis; 2008 Nov; 47(10):1345-53. PubMed ID: 18834317
[TBL] [Abstract][Full Text] [Related]
10. Implementing the number needed to harm in clinical practice: risk of myocardial infarction in HIV-1-infected patients treated with abacavir.
Kowalska JD; Kirk O; Mocroft A; Høj L; Friis-Møller N; Reiss P; Weller I; Lundgren JD
HIV Med; 2010 Mar; 11(3):200-8. PubMed ID: 19863618
[TBL] [Abstract][Full Text] [Related]
11. Impact of antiretroviral choice on hypercholesterolaemia events: the role of the nucleoside reverse transcriptase inhibitor backbone.
Jones R; Sawleshwarkar S; Michailidis C; Jackson A; Mandalia S; Stebbing J; Bower M; Nelson M; Gazzard BG; Moyle GJ
HIV Med; 2005 Nov; 6(6):396-402. PubMed ID: 16268821
[TBL] [Abstract][Full Text] [Related]
12. Risk of hospitalization for myocardial infarction among users of rofecoxib, celecoxib, and other NSAIDs: a population-based case-control study.
Johnsen SP; Larsson H; Tarone RE; McLaughlin JK; Nørgård B; Friis S; Sørensen HT
Arch Intern Med; 2005 May; 165(9):978-84. PubMed ID: 15883235
[TBL] [Abstract][Full Text] [Related]
13. Effects of combination antiretroviral therapies on the risk of myocardial infarction among HIV patients.
Brouwer ES; Napravnik S; Eron JJ; Stalzer B; Floris-Moore M; Simpson RJ; Stürmer T
Epidemiology; 2014 May; 25(3):406-17. PubMed ID: 24713880
[TBL] [Abstract][Full Text] [Related]
14. Hypertension Risk with Abacavir Use among HIV-Infected Individuals: A Nationwide Cohort Study.
Kim J; Bang JH; Shin JY; Yang BR; Lee J; Park BJ
Yonsei Med J; 2018 Dec; 59(10):1245-1252. PubMed ID: 30450860
[TBL] [Abstract][Full Text] [Related]
15. Impact of injecting drug use on response to highly active antiretroviral treatment in HIV-1-infected patients: a nationwide population-based cohort study.
Larsen MV; Omland LH; Gerstoft J; Røge BT; Larsen CS; Pedersen G; Obel N; Kronborg G
Scand J Infect Dis; 2010 Dec; 42(11-12):917-23. PubMed ID: 20840000
[TBL] [Abstract][Full Text] [Related]
16. Abacavir use and cardiovascular disease events: a meta-analysis of published and unpublished data.
Cruciani M; Zanichelli V; Serpelloni G; Bosco O; Malena M; Mazzi R; Mengoli C; Parisi SG; Moyle G
AIDS; 2011 Oct; 25(16):1993-2004. PubMed ID: 21716077
[TBL] [Abstract][Full Text] [Related]
17. Role of hepatitis C virus (HCV) viremia and HCV genotype in the immune recovery from highly active antiretroviral therapy in a cohort of antiretroviral-naive HIV-infected individuals.
Antonucci G; Girardi E; Cozzi-Lepri A; Capobianchi MR; De Luca A; Puoti M; Petrelli E; Carnevale G; Rizzardini G; Grossi PA; Viganò P; Moioli MC; Carletti F; Solmone M; Ippolito G; Monforte AD; ;
Clin Infect Dis; 2005 Jun; 40(12):e101-9. PubMed ID: 15909251
[TBL] [Abstract][Full Text] [Related]
18. Mortality after myocardial infarction in HIV-infected patients who have initiated HAART.
Rasmussen LD; Gerstoft J; Kronborg G; Larsen CS; Pedersen G; Obel N
AIDS; 2007 Apr; 21(7):873-5. PubMed ID: 17415045
[TBL] [Abstract][Full Text] [Related]
19. Predictors of optimal viral suppression in patients switched to abacavir, lamivudine, and zidovudine: the Swiss HIV Cohort Study.
Wolbers M; Opravil M; von Wyl V; Hirschel B; Furrer H; Cavassini M; Vernazza P; Bernasconi E; Battegay M; Yerly S; Günthard H; Bucher HC;
AIDS; 2007 Oct; 21(16):2201-7. PubMed ID: 18090047
[TBL] [Abstract][Full Text] [Related]
20. Risk of myocardial infarction in parents of HIV-infected Individuals: a population-based Cohort Study.
Rasmussen LD; Omland LH; Pedersen C; Gerstoft J; Kronborg G; Jensen J; Obel N
BMC Infect Dis; 2010 Jun; 10():169. PubMed ID: 20546604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
